Holen Sie sich die Stockscreener-App
42.82
2.09%
-0.8266
Finanzdaten der Avidity Biosciences Inc-Aktie (RNA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
61.56%
3.543
|
2.193 | 2.818 | 2.316 | 2.233 |
Operating Expenses
|
17.11%
80.73
|
68.94 | 61.44 | 54.95 | 59.83 |
| Benefits Costs and Expenses |
15.59%
72.40
|
62.64 | - | - | 54.63 |
| Costs And Expenses |
15.59%
72.40
|
62.64 | 61.44 | 54.95 | 54.63 |
| Operating Income/Loss |
15.65%
-77.19
|
-66.74 | -58.62 | -52.63 | -57.60 |
| Nonoperating Income/Loss |
32.25%
8.332
|
6.30 | 6.267 | 5.609 | 5.202 |
| Income/Loss From Continuing Operations Before Tax |
13.92%
-68.86
|
-60.44 | 2.818 | -47.02 | -52.39 |
| Income/Loss From Continuing Operations After Tax |
13.92%
-68.86
|
-60.44 | -52.36 | -47.02 | -52.39 |
|
Net Income/Loss
|
13.92%
-68.86
|
-60.44 | -52.36 | -47.02 | -52.39 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
8,408%
87.21
|
1.025 | 74.10 | 71.39 | 70.43 |
| Diluted Average Shares |
8,408%
87.21
|
1.025 | 74.10 | 71.39 | 70.43 |
| Basic Earnings Per Share |
1.25%
-0.79
|
-0.80 | -0.71 | -0.66 | -0.74 |
| Diluted Earnings Per Share |
1.25%
-0.79
|
-0.80 | -0.71 | -0.66 | -0.74 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):